These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3518936)
21. Choosing drug therapy for patients with hyperlipidemia. Safeer RS; Lacivita CL Am Fam Physician; 2000 Jun; 61(11):3371-82. PubMed ID: 10865931 [TBL] [Abstract][Full Text] [Related]
22. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction. Kind AH; Zakowski LJ; McBride PE WMJ; 2002; 101(7):53-6. PubMed ID: 12426921 [TBL] [Abstract][Full Text] [Related]
23. When and how to treat hyperlipidemia. Kuo PT Prim Care; 1985 Mar; 12(1):77-89. PubMed ID: 3873080 [TBL] [Abstract][Full Text] [Related]
24. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy. Oki JC Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166 [TBL] [Abstract][Full Text] [Related]
25. Treatment of hyperlipidemia in elderly persons with exercise training, nonpharmacologic therapy, and drug combinations. Lavie CJ Am J Geriatr Cardiol; 2004; 13(3 Suppl 1):29-33. PubMed ID: 15133427 [TBL] [Abstract][Full Text] [Related]
26. Safety of niacin and simvastatin combination therapy. Bays H Am J Cardiol; 2008 Apr; 101(8A):3B-8B. PubMed ID: 18375239 [TBL] [Abstract][Full Text] [Related]
27. Advances in drug treatment of dyslipidemia: focus on atorvastatin. Davignon J Can J Cardiol; 1998 May; 14 Suppl B():28B-38B. PubMed ID: 9627539 [TBL] [Abstract][Full Text] [Related]
28. Addition to labeling of cholestyramine. FDA Drug Bull; 1985 Apr; 15(1):7-8. PubMed ID: 3858190 [No Abstract] [Full Text] [Related]
29. Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy. Polonsky TS; Davidson MH Am J Cardiol; 2008 Apr; 101(8A):27B-35B. PubMed ID: 18375238 [TBL] [Abstract][Full Text] [Related]
30. The safety of niacin in the US Food and Drug Administration adverse event reporting database. Alsheikh-Ali AA; Karas RH Am J Cardiol; 2008 Apr; 101(8A):9B-13B. PubMed ID: 18375244 [TBL] [Abstract][Full Text] [Related]
32. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial. Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476 [TBL] [Abstract][Full Text] [Related]
33. Pharmacist management of a hyperlipidemia clinic. Furmaga EM Am J Hosp Pharm; 1993 Jan; 50(1):91-5. PubMed ID: 8427286 [TBL] [Abstract][Full Text] [Related]
34. Effects of gemfibrozil on serum lipids. Samuel P Am J Med; 1983 May; 74(5A):23-7. PubMed ID: 6573843 [TBL] [Abstract][Full Text] [Related]
35. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
36. Hyperlipidemia: perspectives in diagnosis and treatment. Yeshurun D; Gotto AM South Med J; 1995 Apr; 88(4):379-91. PubMed ID: 7716588 [TBL] [Abstract][Full Text] [Related]
37. Identifying and managing patients with hyperlipidemia. Clark AB; Holt JM Am J Manag Care; 1997 Aug; 3(8):1211-9; quiz 1223-5. PubMed ID: 10170303 [TBL] [Abstract][Full Text] [Related]
38. [Hyperlipidemia: therapeutic principles in clinical practice]. Müller-Wieland D; Krone W Med Klin (Munich); 2003 Dec; 98(12):739-43. PubMed ID: 14685674 [TBL] [Abstract][Full Text] [Related]
39. Dietitian intervention improves lipid values and saves medication costs in men with combined hyperlipidemia and a history of niacin noncompliance. Sikand G; Kashyap ML; Wong ND; Hsu JC J Am Diet Assoc; 2000 Feb; 100(2):218-24. PubMed ID: 10670395 [TBL] [Abstract][Full Text] [Related]
40. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. Breuer HW Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]